Previous 10 | Next 10 |
NASDAQ: CORV TSX: CORV VANCOUVER , Dec. 10, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that NASDAQ and the Toronto Stock Exchange (TSX) have halted trad...
Synthorx (NASDAQ: THOR ) +169% on being acquired by Sanofi. More news on: Synthorx, Inc., XBiotech Inc., ArQule, Inc., Stocks on the move, Read more ...
Gainers: Genesco (NYSE: GCO ) +33% . More news on: Genesco Inc., Wellesley Bancorp, Inc., Big Lots, Inc., Stocks on the move, Read more ...
Taronis Technologies (NASDAQ: TRNX ) -30% . More news on: Taronis Technologies, Inc., Correvio Pharma Corp., Yext, Inc., Stocks on the move, Read more ...
NASDAQ: CORV TSX: CORV VANCOUVER , Nov. 25, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mark H.N. Corrigan , MD, Chief Executive Officer of Correvi...
Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual Meeting Canada NewsWire VANCOUVER, Nov. 18, 2019 NASDAQ: CORV TSX: CORV Post Hoc Analysis of Subset of Patients Treated in the Emergency Depa...
Correvio Pharma Corp. (CORV) Q3 2019 Earnings Conference Call November 14, 2019 08:30 AM ET Company Participants Brendan Payne – Associate Director-Investor Relations and Business Development Mark Corrigan – Chief Executive Officer Justin Renz – President and...
Correvio Pharma (NASDAQ: CORV ): Q3 GAAP EPS of -$0.23 misses by $0.06 . More news on: Correvio Pharma Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...
NASDAQ: CORV TSX: CORV FDA Accepts Brinavess™ New Drug Application Advisory Committee Date Set for December 10, 2019 PDUFA Date Set for December 24, 2019 Management to Host Conference Call and Webcast Today, November 14, 2019 at 8:30 a.m. Eastern ( ...
Correvio to Report Third Quarter 2019 Financial Results Canada NewsWire VANCOUVER, Nov. 7, 2019 NASDAQ: CORV TSX: CORV Conference Call Scheduled for Thursday, November 14, 2019 at 8:30 a.m. Eastern ( 5:30 a.m. Pacific) VANCOUVER , Nov. 7, 2019 /CNW/ - ...
News, Short Squeeze, Breakout and More Instantly...
Correvio Pharma Corp. Company Name:
CORV Stock Symbol:
NASDAQ Market:
Correvio Pharma Corp. Website:
NASDAQ: CORV TSX: CORV VANCOUVER , May 21, 2020 /PRNewswire/ - Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order...
Correvio Announces Results from Annual General and Special Meeting of Securityholders Canada NewsWire VANCOUVER, May 15, 2020 Securityholders Approve ADVANZ PHARMA Acquisition NASDAQ: CORV TSX: CORV VANCOUVER , May 15, 2020 /CNW/ - Correvio Pharma Cor...
NASDAQ: CORV TSX: CORV VANCOUVER , May 6, 2020 /PRNewswire/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, released a report...